Search for: "Lilly France"
Results 81 - 100
of 135
Sort by Relevance
|
Sort by Date
28 Apr 2013, 8:40 am
This certainly increases the litigation's complexity, but also allows a patent assertion entity to exploit the inconsistencies to identify the most PAE-friendly courts (look here for a comparison between UK, Germany, France and Netherlands). [read post]
4 Jan 2013, 2:53 pm
Meantime, Eli Lilly, in court documents, is claiming that there isn’t any evidence, even medical records, showing that the Melnick sisters’ mom, Frances Melnick, even took DES. [read post]
27 Nov 2012, 8:43 am
The Judge therefore found that, by virtue of Lilly’s European patent department dealing with Lilly USA’s patents from Lilly UK’s site, and particularly the role of Lilly’s representative before the EPO, Lilly USA has a place of business in England for the purposes English jurisdictional rules. [read post]
17 Oct 2012, 2:05 pm
(He did spend time in France, you know). [read post]
16 Apr 2012, 7:42 am
Trade Secrets Jeannie Fromer Trade secret and patent are not as absolute as we imagine them in terms of disclosure/openness. [read post]
26 Mar 2012, 3:21 am
In 2009, Eli Lilly and Co. shelled out $1.4 billion to settle charges that it marketed Zyprexa to nursing homes, among other health-care providers, as a sleep aid. [read post]
12 Mar 2012, 8:13 am
In December 1833, the American Monthly Review commented on a newly published book by Joseph Story. [read post]
23 Jan 2012, 11:04 am
In addition, both France and Germany have either banned or placed significant restrictions on the prescription of Actos. [read post]
23 Jan 2012, 7:48 am
This announcement in the U.S. followed a more aggressive approach taken in France and Germany, which have both suspended sales and prescriptions of Actos. [read post]
23 Jan 2012, 6:58 am
Actos is manufactured by Takeda Pharmaceutical Company and co-marketed by Eli Lilly and Company. [read post]
11 Jan 2012, 9:44 pm
Actos has been a huge success for Takeda, as Both Takeda and Eli Lilly marketed the drug in Japan, the United States, France and Germany. [read post]
5 Jan 2012, 3:10 pm
France suspended the drug and Germany recommended not to start new patients on the drug due to mounting concerns for their citizens. [read post]
4 Jan 2012, 9:20 am
France suspended the drug and Germany recommended not to start new patients on the drug due to mounting concerns for their citizens. [read post]
3 Jan 2012, 5:38 pm
France and Germany pulled pioglitazone-containing medicines from the market in July of 2011. [read post]
8 Dec 2011, 9:32 am
Actos has been marketed in the U.S. by Eli Lilly & Company of Indianapolis. [read post]
7 Oct 2011, 4:18 am
“Canada DMCA” expected to pass (Ars Technica) Liberals on the Copyright Bill: Digital lock rules driven by US (Michael Geist) The daily digital lock dissenter, day 1: The Provincial Resource Centre for the Visually Impaired (Michael Geist) The daily digital lock dissenter, day 2: Canadian Consumer Initiative (Michael Geist) The daily digital lock dissenter, day 3: Retail Council of Canada (Michael Geist) The daily digital lock dissenter, day 4: Canadian Council of Archives (Michael… [read post]
28 Sep 2011, 1:56 am
(Kluwer Patent Blog) Gabitril (Tiagabine) – US: Cephalon files suits against Sun Pharma. in New Jersey and Michigan in response to Para IV certification (Patent Docs) Glivec (Imatinib) – India: Novartis Glivec patent case: preliminary objection (Spicy IP) Lovenox (Enoxaparin) – US: Momenta files patent infringement complaint against Amphastar in response to impending launch of generic Lovenox (Patent Docs) Lumigan (Bimatoprost) – US: Validity of Allergan Lumigan patents… [read post]
17 Sep 2011, 5:43 am
In response to the European study, both France and Germany have pulled Actos from the market altogether. [read post]
1 Sep 2011, 3:47 am
” The data was presented at the Alzheimer’s Association International Conference in France. [read post]
3 Aug 2011, 3:31 am
: Cour d’Appel Paris decision in Teva v Eli Lilly (Kluwer Patent Blog) US: CAFC confirms that isolated DNA may be patented: Association for Molecular Pathology v. [read post]
